ORYZON receives US patent allowance for vafidemstat BPD treatment
Go back to ORYZON receives US patent allowance for vafidemstat BPD treatment| ORION MARINE GROUP, Inc. (NYSE: ORN) | Delayed: 9.42 +0.34 (3.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.08 | 52 Week High | $9.48 | |||
| Open | $9.21 | 52 Week Low | $3.25 | |||
| Day High | $9.50 | P/E | N/A | |||
| Day Low | $9.20 | EPS | $-0.01 | |||
| Volume | 80,629 | |||||
